These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 12876861)

  • 1. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H; Sahović V; Mesić E; Leto E
    Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
    Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
    Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report.
    El-Amin HH; Osman EM; Mekki MO; Abdelraheem MB; Ismail MO; Yousif ME; Abass AM; El-haj HS; Ammar HK
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):101-6. PubMed ID: 17237901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco].
    Sekkat S; Kamal N; Benali B; Fellah H; Amazian K; Bourquia A; El Kholti A; Benslimane A
    Nephrol Ther; 2008 Apr; 4(2):105-10. PubMed ID: 18272446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
    Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
    P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A high prevalence of hepatitis C in hemodialysis].
    Resic H; Borovac N; Leto E
    Med Arh; 2001; 55(4):235-7. PubMed ID: 11769454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient to patient transmission of hepatitis C virus in hemodialysis units.
    Taskapan H; Oymak O; Dogukan A; Utas C
    Clin Nephrol; 2001 Jun; 55(6):477-81. PubMed ID: 11434360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence and prevalence of anti-HVC antibodies and HBV markers in patients undergoing extracorporeal hemodialysis].
    Incandela L; Giomi S; Nencioni C; Riccardi MP; Galluzzi P; Caponetti R; Domenici P; Toti M
    Minerva Med; 1994 Oct; 85(10):505-9. PubMed ID: 7800191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C infection in a pediatric dialysis population.
    Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
    Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia].
    Ben Othman S; Bouzgarrou N; Achour A; Bourlet T; Pozzetto B; Trabelsi A
    Pathol Biol (Paris); 2004 Jul; 52(6):323-7. PubMed ID: 15261374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C viral infection in a Chinese hemodialysis unit.
    Li H; Wang SX
    Chin Med J (Engl); 2010 Dec; 123(24):3574-7. PubMed ID: 22166633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003.
    Kumagai J; Komiya Y; Tanaka J; Katayama K; Tatsukawa Y; Yorioka N; Miyakawa Y; Yoshizawa H
    J Med Virol; 2005 Aug; 76(4):498-502. PubMed ID: 15977246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
    Selm SB
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.